Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.88−0.12 (-1.33%)
Close on Nov 17, 2026Market cap $93.69MP/E –Yield –
Biodesix operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Biodesix's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.83M. For fiscal 2025 it was -$23.27M. The highest annual figure on record is -$21.37M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.27M | – |
| FY2024 | Dec 31, 2024 | -$48.65M | – |
| FY2023 | Dec 31, 2023 | -$22.87M | – |
| FY2022 | Dec 31, 2022 | -$44.97M | – |
| FY2021 | Dec 31, 2021 | -$28.22M | – |
| FY2020 | Dec 31, 2020 | -$21.37M | – |
| FY2019 | Dec 31, 2019 | -$21.73M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.17M | – |
| Q4 FY2025 | Dec 31, 2025 | $778.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.88M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.57M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.10M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$18.57M | -2082.0% |
| Q1 FY2024 | Mar 31, 2024 | -$15.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.28M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.84M | – |
| Q2 FY2023 | Jun 30, 2023 | $937.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.95M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.33M | – |
| Q2 FY2022 | Jun 30, 2022 | -$9.59M | -980.2% |
| Q1 FY2022 | Mar 31, 2022 | -$13.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.79M | – |
| Q2 FY2021 | Jun 30, 2021 | $1.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.33M | – |
| Q4 FY2020 | Dec 31, 2020 | -$8.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.77M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.30M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.54M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.73M | – |
See a number that looks wrong?